tinea%20capitis%20(pediatric)
TINEA CAPITIS (PEDIATRIC)
Tinea capitis lesions are a type of contagious dermatophytosis that are found on the scalp, hair follicles and/or surrounding skin.
It is most common in the crowded areas as infection originates from contact with a pet or an infected person and asymptomatic carriage persists indefinitely.
It primarily affects children 3-7 year of age.
The causative agents are the genus Trichophyton and Microsporum.
Cardinal clinical feature is the combination of inflammation with hair breakage and loss.

Patient Education

  • Educate the patient/guardian about the contagiousness of the disease
    • Explain that sharing of toys or personal objects (eg combs & hairbrushes) can spread the infection, thus should be avoided
    • Identify & treat asymptomatic carriers including family members, caretakers & playmates
    • Treat or remove animals or pets infected w/ M. canis
    • Disinfect belongings of infected patients such as hairbrushes, combs, beddings, etc
  • Reassure the parent/caregiver that patients receiving treatment for Tinea capitis may attend school
  • Haircuts, shaving of the head & wearing a cap during treatment are usually unnecessary
  • Follow-up visits are needed for assessment of treatment response
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Mar 2018
During the Kuala Lumpur International Neonatology Conference held in conjunction with the World Prematurity Day 2017, Dato Dr Musa Mohd Nordin spoke on the importance of immunizing children with the diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine. He highlighted the role of Hexaxim® as a fully liquid, ready-to-use, 6-in-1 (including hepatitis B) vaccine for the primary and booster vaccinations of infants and toddlers. Meanwhile, Dr Yong Junina Fadzil discussed the benefits of quadrivalent influenza vaccines (QIVs) in providing children with broader protection against influenza B viruses.